Program:
Medical College of Wisconsin
MONIQA™: Automated Quality Assurance for Radiation Therapy
Technology Sectors:
Health & Bio, Medical Devices & Imaging
The Opportunity: Making Cancer Treatment Safer and More Efficient | Radiation therapy is used to treat millions of cancer patients each year and requires precise coordination between treatment planning, data transfer, and treatment delivery. While errors are rare, they do occur and can have serious consequences. Safe treatment depends on many quality checks to create
Program:
Medical College of Wisconsin
An Improved Connector Design to Reduce Stroke Risk
Technology Sectors:
Health & Bio
The Opportunity: Safer Blood Circuits for Life-Support and Dialysis Systems | Extracorporeal medical systems such as ECMO, dialysis, and cardiopulmonary bypass rely on tubing circuits that move blood outside the body for treatment. Connection points within these circuits can create disruptions in blood flow that increase the risk of clot formation, blood cell damage, and
Program:
Medical College of Wisconsin
Adaptive Dose‑Tracking Software for Radiation Therapy
Technology Sectors:
Health & Bio, Medical Devices & Imaging
A truer picture of radiation dose for individualized cancer care As patients change during treatment, this innovation enables radiation dose assessment to change with them. By moving beyond static assumptions, it supports more accurate insight into how therapy affects tumors and healthy tissue—helping advance truly adaptive cancer treatment.
Program:
Medical College of Wisconsin
Augmented Reality‑Guided MRI Procedures
Technology Sectors:
Medical Devices & Imaging
Making MRI‑guided care clearer, faster, and safer By giving clinicians GPS‑like visual cues inside the MRI, this technology points toward a new standard for image‑guided care—where procedures are more precise, take less time, and place less burden on both patients and clinical teams.
Program:
Medical College of Wisconsin
Next‑Generation Lyme Disease Vaccine
Technology Sectors:
Health & Bio
Longer‑term protection for people and pets at risk As Lyme risk continues to expand, this innovation points toward a new generation of vaccines designed for durability—not short‑lived immunity. The approach aims to provide broader, longer‑term protection for both people and pets in regions where Lyme disease is becoming a persistent and growing threat.